News | October 27, 2025
Sigachi Industries posts Q2 FY2026 consolidated profit at Rs. 10.68 Cr
Sigachi Industries has reported total income of Rs. 112.97 crore during the period ended September 30, 2025
Sigachi Industries has reported total income of Rs. 112.97 crore during the period ended September 30, 2025
Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis
Dr Reddys Laboratories has reported total income of Rs. 8,805.1 crore during the period ended September 30, 2025
Agreement adds a new preclinical ADC with potential for enhanced anti-tumour activity and best-in-class profile
Efdoralprin Alfa was well tolerated, with a safety profile comparable to plasma-derived therapy
INEOS production of BDO in Germany, which produces a vital ingredient for antibiotics, statins and vitamin B6, is being crushed by a flood of carbon heavy imports and product dumping from the Far East
Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or desirable
The company’s “greener” initiatives emphasize eco-friendly excipients and energy-efficient manufacturing processes that reduce environmental impact without compromising product quality
OS is a key secondary endpoint of the 948-patient study, which is evaluating whether adding AstraZeneca's PD-L1 inhibitor to standard FLOT chemotherapy
The product is indicated for the chronic management of patients with Urea Cycle Disorders
Subscribe To Our Newsletter & Stay Updated
